ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Letter Goes On Vacation

August 16, 1985

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

Clinton To Propose $1 Billion Increase And A New Minority Health Center For NIH.

January 21, 2000

NCI Program: DOD’s TRICARE To Cover Patient Costs In NCI Prevention, Early detection Trials

September 10, 1999

Henles to Get Bristol-Myers $25,000 Award

March 23, 1979

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

December 7, 1979